首页> 美国政府科技报告 >Tamper-Resistant Packing Requirements for Certain Over-the-Counter (OTC) Human Drug Products. FDA Compliance Guides. Chapter 32A. Drug Adulteration Guide 7132A.17

【24h】

Tamper-Resistant Packing Requirements for Certain Over-the-Counter (OTC) Human Drug Products. FDA Compliance Guides. Chapter 32A. Drug Adulteration Guide 7132A.17

机译：某些非处方（OTC）人用药品的防篡改包装要求。 FDa合规指南。第32a章。药物掺假指南7132a.17

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

The guide discusses the requirements for the use of tamper resistant packaging for certain over the counter human drug products. It provides policy stipulations for the following: film wrappers, blister or strip pack; bubble packs; heat shrink bands or wrappers; foil, paper, or plastic seals; container mouth inner seals; tape seals; breakable caps; and others. Also presented is a review of capsule sealing technologies.

著录项

作者

展开▼
作者单位

展开▼
年度 1992
页码 p.1-9
总页数 9
原文格式 PDF
正文语种 eng
中图分类工业技术;
关键词
Packaging ; Drugs ; Containers ; Plastics ; Polymeric films ; Seals(Stoppers) ; Foils(Materials) ; Requirements ; Regulations ; Guidelines;

机译：包装;药品;容器;塑料;聚合物薄膜;密封件（塞子）;箔（材料）;要求;法规;指南;

相似文献

外文文献
中文文献

1. Manufacturers' Compliance with the US Food and Drug Administration's Over-the-Counter Human Drugs: Labeling Requirements [J] . Sujit S. Sansgiry, Gauri Shringarpure Packaging Technology and Science . 2003,第3期

机译：制造商对美国食品药品监督管理局非处方人类药品的合规性：标签要求
2. Safety and effectiveness of over-the-counter drugs: The FDA's OTC drug review [J] . Food and Drug Administration Pediatrics: Official Publication of the American Academy of Pediatrics . 1977,第2期

机译：非处方药的安全性和有效性：FDA的OTC药品审查
3. How to Meet Compliance and Records Requirements of the US Food and Drug AdministrationJohn Avellanet describes an 11-step strategy on how companies can implement effective document control to avoid falling foul of the US FDA. [J] . John Avellanet The regulatory affairs journal: Pharma . 2009,第6期

机译：如何满足美国食品药品监督管理局的合规性和记录要求约翰·阿维拉内特（John Avellanet）描述了一个11步策略，说明公司如何实施有效的文件控制，以避免违反美国FDA。
4. Manufacture, Distribution, and Promotion of Adulterated, Misbranded, orUnapproved New Drugs for Human Use by State-Licensed Pharmacies. FDA Compliance Policy Guides. Chapter 32-Drugs General [R] . 1992

机译：制造，分发和推广由国家许可的药房供人用的掺假，贴错标签或未经批准的新药。 FDa合规政策指南。第32章 - 药物总则

Tamper-Resistant Packing Requirements for Certain Over-the-Counter (OTC) Human Drug Products. FDA Compliance Guides. Chapter 32A. Drug Adulteration Guide 7132A.17

摘要

著录项

相似文献

相关主题

期刊订阅